## Multidrug resistance (MDR) is developed in a population of somatic mammalian cells in vivo or in vitro when they are selected for resistance to each of a large group of drugs (colchicine, adriamycin, actinomycin D , etc.). It isproduced by the amplification of some unknown gene@) whose praduct(s)
β¦ LIBER β¦
Multidrug resistance in cancer cells, molecular, biochemical, physiological and biological aspects
- Book ID
- 108422142
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- French
- Weight
- 135 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0223-5234
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Gene amplification in multidrug-resistan
β
Andrey Gudkov; Boris Kopnin
π
Article
π
1985
π
John Wiley and Sons
π
English
β 659 KB
Bypassing Multidrug Resistance in Cancer
β
Yan Yan; Christopher J. Ochs; Georgina K. Such; Joan K. Heath; Edouard C. Nice;
π
Article
π
2010
π
John Wiley and Sons
π
English
β 806 KB
Molecular and Physiologic Mechanisms of
β
R.S. Kerbel
π
Article
π
2001
π
Springer
π
English
β 33 KB
Expression of the mutated p53 tumor supp
β
Ogretmen, Besim; Safa, Ahmad R
π
Article
π
1997
π
Nature Publishing Group
π
English
β 610 KB
Elevation of glucosylceramide in multidr
β
Hamid Morjani; NassΓ©ra Aouali; Rajae Belhoussine; Robert Jan Veldman; Thierry Le
π
Article
π
2001
π
John Wiley and Sons
π
French
β 261 KB
Multidrug-resistant (MDR) cancer cells have been shown to have an accumulation of glucosylceramide (GlcCer). In this study, we aim at localizing, at subcellular level, where these lipids accumulate. Neutral lipids and phospholipid containing organelles have been identified using confocal fluorescenc
Changes in phospholipase D isoform activ
Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells
β
Giusy Fiucci; Malgorzata Czarny; Yaakov Lavie; Di Zhao; Brygida Berse; J. Krzysz
π
Article
π
2000
π
John Wiley and Sons
π
French
β 171 KB
Multidrug resistance (MDR) is a major cause of failure of cancer chemotherapy and is often associated with elevated expression of drug transporters such as P-glycoprotein (P-gp) in the cancer cells. MDR is, however, accompanied by additional biochemical changes including modifications of membrane co